UniTao Pharma of China Buys US Plant from Boehringer Ingelheim

China's UniTao Pharma bought an about-to-idled Boehringer Ingelheim plant in Virginia, and the company will invest $22.5 million in the facility to make APIs. BI was going to close the plant by the end of 2014, laying off 240 employees. UniTao has promised to hire 376 people to staff its operations, though the BI employees will have to apply for their old jobs. UniTao is a subsidiary of Shanghai Tenry Pharmaceutical Co. More details.... Share this with colleagues: // //